Prosecution Insights
Last updated: October 01, 2026

Examiner: RITCHIE, HADEN MATTHEW

Tech Center 3700 • Art Units: 3774 3783 3791

This examiner grants 73% of resolved cases

Analysis

Examiner Haden Matthew Ritchie works in Tech Center 3700 and Art Unit 3774. The examiner has 64 resolved cases, offering a moderate sample size for evaluating prosecution trends. The allowance rate is 73.4%, which is high and suggests a favorable environment for applicants. This 73.4% rate indicates that a majority of cases result in a granted patent.

The interview lift is 33.8%. This figure shows that interviews provide a significant benefit, even with a strong baseline allowance rate. The 33.8% lift suggests that direct engagement can be a very effective way to resolve any remaining issues and secure an allowance in Art Unit 3774.

The median days to allowance is 1319. This timeline provides a benchmark for the expected duration of the examination process. With 64 resolved cases, the examiner's 73.4% allowance rate and 1319-day median pendency offer a promising outlook. The combination of high success rates and a positive interview lift suggests a predictable prosecution path for applicants.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

73.4%
Allow Rate
+3.4% vs TC avg
98
Total Applications
+33.8%
Interview Lift
1319
Avg Prosecution Days
Based on 64 resolved cases, 2023–2026

Rejection Statute Breakdown

0.8%
§101 Eligibility
36.4%
§102 Novelty
50.1%
§103 Obviousness
11.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17863512 CLOSED LOOP SMOKE FILTRATION SYSTEM Final Rejection Covidien LP
17614077 DUAL CHAMBER DRUG RESERVOIR AND STOPPER THEREFOR Final Rejection Novo Nordisk A/S
18640302 HYPOTUBE WITH PROGRESSIVE BENDING STIFFNESS AND IMPROVED TENSILE STRENGTH Non-Final OA STRYKER EUROPEAN OPERATIONS LIMITED
19085327 Endoscopic Submucosal Drug Delivery System Non-Final OA Carnegie Mellon University
17945691 CATHETER Non-Final OA ASAHI INTECC CO., LTD.
17603747 Apparatus for Detecting a Dose of Medicament Delivered from an Injection Device Final Rejection Sanofi
18196262 TUBE SECUREMENT DEVICE AND METHODS Non-Final OA The Board of Regents of The University of Texas System
17889323 CATHETER ASSEMBLY Non-Final OA TERUMO KABUSHIKI KAISHA
18655166 Systems and Methods for Monitoring Operations of an Infusion Delivery Device Using a Pressure Sensor Non-Final OA INSULET CORPORATION
17439392 SYRINGE AUXILIARY TOOL Final Rejection TAISEI KAKO CO., LTD.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month